The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial shows significant symptom reduction ...

Following recent approvals in the EU, US and China, the Singapore approval is based on two replicate phase 3 studies that showed Dupixent achieved significant reduction in exacerbations, and also ...

Pregnant patients with T2IDs using dupilumab did not have an increased rate of adverse events when compared with patients not receiving dupilumab.

The Trump administration apparently has backed away from a proposal to eliminate funding for Head Start, the early education program that serves some of the nation's neediest preschoolers.

The White House plans to cut staffing at the CIA and other intelligence agencies, including the National Security Agency, Trump administration officials told members of Congress, The Washington ...

Benralizumab and dupilumab injections specifically target ... which the Food and Drug Administration (FDA) approved as an emphysema treatment in 2018. A surgeon implants this device into a person ...

The Trump administration threatened to withhold federal funding from states that did not enforce its interpretation of civil rights law. By Sarah Mervosh A coalition of 19 states sued the Trump ...